| Title |
Published |
|
Extended-Release Naltrexone and Buprenorphine-Naloxone Equally Safe and Effective: Outcomes from CTN-0051
|
12/01/2017
|
|
Young Adults with Stimulant Use Disorder May Benefit from the STAGE-12 Intervention
|
12/01/2017
|
|
Strength in the Midst of Pain: Abuse as a Predictor of Sexual Relationship Power
|
11/01/2017
|
|
Strong Acceptability of Web-Based Intervention (TES) Among Racial/Ethnic Minority Populations
|
11/01/2017
|
|
Smartphone-Based Intervention from CTN-0044 Approved by the FDA for Marketing
|
10/01/2017
|
|
First Paper from the CTN Study on Testing and Linkage to HIV Care in China Published
|
10/01/2017
|
|
Tobacco-Free Grounds Policies in Treatment Programs Reduce Smoking for Clients and Staff
|
09/01/2017
|
|
Clonidine Increases Likelihood of Abstinence in Buprenorphine-Maintained Patients Facing Risky Amounts of Structured Time
|
09/01/2017
|
|
Substance Use Disorders Prevalent in Adult Primary Care Patients
|
08/01/2017
|
|
Clinical Characteristics of Women with PTSD and Concurrent Cannabis & Cocaine Use Disorders
|
08/01/2017
|
|
Prescription Opioid Registry Protocol in Integrated Health System
|
07/01/2017
|
|
N-Acetylcysteine Not Effective for Treating Cannabis Use Disorder in Adults – CTN-0053 Outcomes
|
07/01/2017
|
|
High Mortality Among Patients with Opioid Use Disorder in General Healthcare System
|
06/01/2017
|
|
Sex Risk Behaviors and Substance Use Severity Among Men in SUD Treatment
|
06/01/2017
|
|
The Prescription Opioid Treatment Study: What Have We Learned?
|
05/01/2017
|
|
Gender Differences in the Relationship Between Education, Alcohol Use Disorder, and Unprotected Sex
|
05/01/2017
|
|
12-Step Sponsorship Associated with Positive Outcomes for Stimulant Users
|
04/01/2017
|
|
Chronic Pain Prevalent Among Patients with Opioid Use Disorder
|
04/01/2017
|
|
Chronic Pain Elevates Risk for Opioid Use During Buprenorphine Taper
|
03/01/2017
|
|
Gender differences among treatment-seeking adults with cannabis use disorder
|
03/01/2017
|
